UNIPHAR PLC (UPR.I) Stock Fundamental Analysis
DUB:UPR - Euronext Dublin - IE00BJ5FQX74 - Common Stock - Currency: EUR
Taking everything into account, UPR scores 4 out of 10 in our fundamental rating. UPR was compared to 23 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of UPR while its profitability can be described as average. UPR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year UPR was profitable.
In the past year UPR had a positive cash flow from operations.
In the past 5 years UPR has always been profitable.
UPR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.18%, UPR is in the better half of the industry, outperforming 65.38% of the companies in the same industry.
UPR has a better Return On Equity (12.90%) than 69.23% of its industry peers.
UPR's Return On Invested Capital of 8.65% is amongst the best of the industry. UPR outperforms 92.31% of its industry peers.
UPR had an Average Return On Invested Capital over the past 3 years of 8.87%. This is above the industry average of 5.35%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.18% | ||
| ROE | 12.9% | ||
| ROIC | 8.65% |
ROA(3y)4.22%
ROA(5y)3.75%
ROE(3y)16.11%
ROE(5y)14.74%
ROIC(3y)8.87%
ROIC(5y)8.58%
1.3 Margins
The Profit Margin of UPR (1.68%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of UPR has grown nicely.
With a Operating Margin value of 2.97%, UPR is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of UPR has grown nicely.
Looking at the Gross Margin, with a value of 15.24%, UPR is doing worse than 61.54% of the companies in the same industry.
UPR's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.97% | ||
| PM (TTM) | 1.68% | ||
| GM | 15.24% |
OM growth 3Y5.76%
OM growth 5Y11.44%
PM growth 3Y4.78%
PM growth 5Y23.56%
GM growth 3Y8.64%
GM growth 5Y13.36%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UPR is creating some value.
UPR has about the same amout of shares outstanding than it did 1 year ago.
UPR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, UPR has a worse debt to assets ratio.
2.2 Solvency
UPR has an Altman-Z score of 2.55. This is not the best score and indicates that UPR is in the grey zone with still only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.55, UPR belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
UPR has a debt to FCF ratio of 5.45. This is a neutral value as UPR would need 5.45 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.45, UPR is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
UPR has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
UPR's Debt to Equity ratio of 1.14 is on the low side compared to the rest of the industry. UPR is outperformed by 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 5.45 | ||
| Altman-Z | 2.55 |
ROIC/WACC1.3
WACC6.68%
2.3 Liquidity
UPR has a Current Ratio of 0.90. This is a bad value and indicates that UPR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.90, UPR is in line with its industry, outperforming 53.85% of the companies in the same industry.
UPR has a Quick Ratio of 0.90. This is a bad value and indicates that UPR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.59, UPR is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.59 |
3. Growth
3.1 Past
UPR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.35%.
UPR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.73% yearly.
The Revenue has grown by 15.64% in the past year. This is quite good.
UPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.48% yearly.
EPS 1Y (TTM)1.35%
EPS 3Y15.71%
EPS 5Y17.73%
EPS Q2Q%9.46%
Revenue 1Y (TTM)15.64%
Revenue growth 3Y11.86%
Revenue growth 5Y12.48%
Sales Q2Q%10.33%
3.2 Future
The Earnings Per Share is expected to grow by 7.62% on average over the next years.
The Revenue is expected to grow by 4.75% on average over the next years.
EPS Next Y8.13%
EPS Next 2Y9.47%
EPS Next 3Y9.72%
EPS Next 5Y7.62%
Revenue Next Year8.94%
Revenue Next 2Y7.02%
Revenue Next 3Y6.48%
Revenue Next 5Y4.75%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
UPR is valuated correctly with a Price/Earnings ratio of 15.94.
UPR's Price/Earnings ratio is a bit cheaper when compared to the industry. UPR is cheaper than 65.38% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. UPR is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 11.90 indicates a reasonable valuation of UPR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UPR indicates a somewhat cheap valuation: UPR is cheaper than 73.08% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, UPR is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.94 | ||
| Fwd PE | 11.9 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UPR is valued a bit cheaper than the industry average as 65.38% of the companies are valued more expensively.
65.38% of the companies in the same industry are more expensive than UPR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.17 | ||
| EV/EBITDA | 8.85 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of UPR may justify a higher PE ratio.
PEG (NY)1.96
PEG (5Y)0.9
EPS Next 2Y9.47%
EPS Next 3Y9.72%
5. Dividend
5.1 Amount
With a yearly dividend of 0.87%, UPR is not a good candidate for dividend investing.
UPR's Dividend Yield is comparable with the industry average which is at 2.93.
Compared to an average S&P500 Dividend Yield of 2.33, UPR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
5.2 History
The dividend of UPR is nicely growing with an annual growth rate of 33.58%!
Dividend Growth(5Y)33.58%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
UPR pays out 11.06% of its income as dividend. This is a sustainable payout ratio.
UPR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP11.06%
EPS Next 2Y9.47%
EPS Next 3Y9.72%
DUB:UPR (3/7/2025, 7:00:00 PM)
2.71
+0.01 (+0.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners44.92%
Inst Owner ChangeN/A
Ins Owners5.43%
Ins Owner ChangeN/A
Market Cap703.60M
Analysts82
Price Target4.63 (70.85%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
Yearly Dividend0.02
Dividend Growth(5Y)33.58%
DP11.06%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.42%
PT rev (3m)1.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.94 | ||
| Fwd PE | 11.9 | ||
| P/S | 0.26 | ||
| P/FCF | 9.17 | ||
| P/OCF | 5.41 | ||
| P/B | 2.01 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.85 |
EPS(TTM)0.17
EY6.27%
EPS(NY)0.23
Fwd EY8.4%
FCF(TTM)0.3
FCFY10.9%
OCF(TTM)0.5
OCFY18.48%
SpS10.33
BVpS1.35
TBVpS-0.86
PEG (NY)1.96
PEG (5Y)0.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.18% | ||
| ROE | 12.9% | ||
| ROCE | 10.25% | ||
| ROIC | 8.65% | ||
| ROICexc | 9.87% | ||
| ROICexgc | 62.46% | ||
| OM | 2.97% | ||
| PM (TTM) | 1.68% | ||
| GM | 15.24% | ||
| FCFM | 2.86% |
ROA(3y)4.22%
ROA(5y)3.75%
ROE(3y)16.11%
ROE(5y)14.74%
ROIC(3y)8.87%
ROIC(5y)8.58%
ROICexc(3y)10.91%
ROICexc(5y)10.66%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.5%
ROCE(5y)10.15%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y4.27%
ROICexc growth 5Y-4.98%
OM growth 3Y5.76%
OM growth 5Y11.44%
PM growth 3Y4.78%
PM growth 5Y23.56%
GM growth 3Y8.64%
GM growth 5Y13.36%
F-Score5
Asset Turnover1.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 5.45 | ||
| Debt/EBITDA | 3.43 | ||
| Cap/Depr | 146.82% | ||
| Cap/Sales | 1.99% | ||
| Interest Coverage | 3.25 | ||
| Cash Conversion | 112.13% | ||
| Profit Quality | 169.77% | ||
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.59 | ||
| Altman-Z | 2.55 |
F-Score5
WACC6.68%
ROIC/WACC1.3
Cap/Depr(3y)71.27%
Cap/Depr(5y)65.55%
Cap/Sales(3y)0.99%
Cap/Sales(5y)0.84%
Profit Quality(3y)87.46%
Profit Quality(5y)184.23%
High Growth Momentum
Growth
EPS 1Y (TTM)1.35%
EPS 3Y15.71%
EPS 5Y17.73%
EPS Q2Q%9.46%
EPS Next Y8.13%
EPS Next 2Y9.47%
EPS Next 3Y9.72%
EPS Next 5Y7.62%
Revenue 1Y (TTM)15.64%
Revenue growth 3Y11.86%
Revenue growth 5Y12.48%
Sales Q2Q%10.33%
Revenue Next Year8.94%
Revenue Next 2Y7.02%
Revenue Next 3Y6.48%
Revenue Next 5Y4.75%
EBIT growth 1Y9.67%
EBIT growth 3Y18.31%
EBIT growth 5Y25.35%
EBIT Next Year50.53%
EBIT Next 3Y19.72%
EBIT Next 5Y13.71%
FCF growth 1Y217.65%
FCF growth 3Y-25.76%
FCF growth 5YN/A
OCF growth 1Y200.26%
OCF growth 3Y-7.33%
OCF growth 5YN/A